Physician profile
Thomas E Shook
NPI 1093896524
$5,556.29
in general payments reported to CMS, 2019-2025
40 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $215 · 2021: $1,213 · 2022: $866 · 2023: $953 · 2024: $610 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,157.66 | 2019-2023 | Lithovue |
| Coloplast Corp | $575.86 | 2019-2025 | Porges Coloplast |
| Pfizer INC. | $485.29 | 2019-2025 | |
| Abbvie INC. | $372.14 | 2020-2025 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $309.08 | 2019-2025 | |
| Astellas Pharma US INC | $276.27 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $257.40 | 2019-2025 | Provenge |
| Procept Biorobotics Corporation | $255.73 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $231.85 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $230.93 | 2021-2025 | Lynparza, Keytruda |
| Endo Pharmaceuticals INC. | $184.92 | 2019-2024 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $169.37 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $119.05 | 2021-2024 | Lynparza |
| Urovant Sciences INC | $102.82 | 2021-2022 | |
| Endo USA, INC. | $69.53 | 2024-2025 | Xiaflex |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $64.64 | 2019-2022 | |
| Urogen Pharma, INC. | $62.62 | 2021-2024 | Jelmyto |
| Myovant Sciences INC. | $61.69 | 2022 | |
| Blue Earth Diagnostics | $48.84 | 2021-2022 | |
| Allergan, INC. | $45.28 | 2019-2021 | |
| Olympus America INC. | $41.90 | 2023-2025 | Itind System |
| Janssen Biotech, INC. | $41.42 | 2019-2024 | Akeega, Balversa, Erleada |
| Ferring Pharmaceuticals INC. | $37.91 | 2019 | |
| Teleflex LLC | $37.85 | 2023 | Urolift |
| Davol INC. | $31.41 | 2024 | Arista Ah Flexitip |
| Tolmar, INC. | $28.38 | 2024 | |
| Verity Pharmaceuticals INC. | $24.83 | 2025 | Tlando |
| Medline Industries Lp | $23.74 | 2024 | |
| Axonics, INC. | $23.54 | 2021 | |
| Accord Healthcare, INC. | $22.55 | 2025 | |
| Antares Pharma, INC. | $22.51 | 2022 | |
| Calyxo, INC. | $21.32 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $19.97 | 2022 | |
| Progenics Pharmaceuticals, INC. | $19.71 | 2023 | Pylarify |
| Telix Pharmaceuticals | $19.38 | 2023 | Illuccix |
| Laborie Medical Technologies Corp. | $14.99 | 2025 | |
| Myriad Genetic Laboratories, INC. | $13.70 | 2023 | Prolaris |
| Neotract INC. | $13.22 | 2019 | |
| Innovation Technologies INC | $13.19 | 2024 | Irrisept |
| Travere Therapeutics, INC. | $3.80 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Shook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.